Root Canal Bacteria and Breast Cancer: New Meta-Analysis Finds No Clear Link, But Clues to Tumor Progression

A sweeping new systematic review has put one of medicine’s more unsettling hypotheses to the test: could bacteria lurking in infected root canals and diseased gums actually raise a woman’s risk of breast cancer? The short answer, according to the analysis published in Holistic Integrative Oncology, is that the epidemiological evidence simply does not add up to a confirmed association. But the longer answer is far more intriguing. While large population studies found no consistent link between oral pathogens and breast cancer incidence, a parallel body of laboratory and translational research suggests these same microbes may play a role in how existing tumors progress, spread, and evade the immune system.

The research team, led by Jasmine Kaur of Gian Sagar Medical College and Hospital in India, together with colleagues from institutions in Georgia, Nigeria, and India, followed rigorous PRISMA 2020 and MOOSE reporting guidelines, with a protocol registered in advance on PROSPERO. They searched PubMed, Embase, Web of Science, and Scopus for human studies published between January 2020 and February 2025 that examined three notorious oral bacteria: Fusobacterium nucleatum, Enterococcus faecalis, and Porphyromonas gingivalis. These species are common culprits in endodontic infections, the deep infections of the tooth pulp and root canal system, and each carries biological credentials that make the cancer hypothesis plausible.

From an initial pool of 150 unique records, 20 studies survived screening and full-text review, encompassing roughly 20,000 breast cancer cases. The studies spanned North America, Europe, Asia, and Africa, with sample sizes ranging from just 30 participants to more than 600,000. Exposure assessment varied widely: some studies used 16S rRNA gene sequencing or quantitative PCR to detect bacterial DNA, others relied on clinical periodontal examinations, antibody titers, or diagnosis codes extracted from insurance claims databases. Study quality was graded using the Newcastle-Ottawa Scale, with studies scoring seven or higher deemed high quality.

Only three studies were statistically compatible enough to pool in a meta-analysis, and the results were strikingly discordant. A large United States cohort of approximately 50,000 women found essentially no association between periodontal disease and breast cancer incidence, reporting a hazard ratio of 1.02 with a confidence interval spanning 0.94 to 1.11. A Greek case-control study, by contrast, reported that women with advanced periodontal disease had 79 percent higher odds of breast cancer, with an odds ratio of 1.79. Most paradoxically, an analysis of a US claims database found that prior Enterococcus infection was associated with a 40 percent reduction in breast cancer incidence, an odds ratio of 0.60. Pooled together, these studies yielded a summary odds ratio of exactly 1.00, with a 95 percent confidence interval of 0.62 to 1.58, meaning no overall association whatsoever.

The statistical heterogeneity between those three studies was extreme, with an I-squared value of 98 percent, indicating that nearly all of the observed variation came from differences between studies rather than chance. Subgroup analyses hinted at a familiar epidemiological pattern: associations appeared stronger in retrospective case-control designs and vanished in prospective cohorts, a signature of selection and recall bias. In case-control studies, patients who already have cancer may remember or report oral health problems differently, or the disease and its treatment may itself alter oral conditions. Sensitivity analyses confirmed the robustness of the null finding, as removing the lowest-quality study barely moved the pooled estimate, shifting it to an odds ratio of 1.02. With only three baseline studies available, the authors acknowledged that more sophisticated subgroup modeling was simply not feasible.

Where the epidemiology faltered, the laboratory evidence grew more compelling. Five studies examined whether F. nucleatum and P. gingivalis physically colonize breast tumors, and several confirmed by quantitative PCR and fluorescence in situ hybridization that F. nucleatum DNA was significantly more abundant in tumor tissue than in adjacent normal tissue. These bacteria were associated with more advanced disease stage and lymph node metastasis. Immunohistochemistry and spatial transcriptomics, techniques that map gene activity within intact tissue architecture, revealed upregulation of oncogenic signaling and immune-suppressive pathways in bacteria-positive tumors, with particularly notable findings in triple-negative breast cancer, the most aggressive subtype.

Animal models added mechanistic weight to these observations. Oral exposure to F. nucleatum and P. gingivalis promoted breast cancer metastasis in mice, apparently through inflammatory cytokine signaling involving interleukin-1 beta, interleukin-6, and CCL2. Tumors colonized by these bacteria showed reduced infiltration by cytotoxic T cells, the immune cells responsible for killing cancer cells, alongside an expansion of myeloid-derived suppressor cells, which dampen anti-tumor immunity. At the molecular level, the implicated pathways include activation of Toll-like receptor 4, engagement of the NF-kappa-B inflammatory cascade, and induction of epithelial-mesenchymal transition, the cellular program that allows stationary epithelial cells to become migratory and invasive. Only three studies tracked patient outcomes, but one linked the presence of intratumoral F. nucleatum to poor response to immunotherapy and lower recurrence-free survival.

The authors are careful to enumerate the caveats. Observational studies remain vulnerable to residual confounding by smoking, antibiotic use, diet, and socioeconomic factors, all of which influence both the oral microbiome and cancer risk. Bacterial detection methods varied so widely across studies that direct comparison is hazardous, and low-biomass tissue samples like breast tissue are notoriously susceptible to contamination, meaning some detected microbes may be laboratory artifacts rather than genuine tumor residents. Most included studies lacked longitudinal follow-up, making it impossible to establish whether bacterial colonization preceded cancer progression or followed it. The predominance of data from high-income countries further limits generalizability to populations with different oral health profiles and cancer risks.

Nevertheless, the convergence of microbiological, immunological, and genomic data points in one direction: F. nucleatum in particular emerges as a potential contributor to breast cancer progression, even if causality for cancer incidence remains unproven. The authors recommend large prospective cohorts with serial oral microbiome sequencing and rigorous confounder control, Mendelian randomization studies to probe causality, spatial multi-omics mapping of bacteria-immune interactions in human tumors, and standardized laboratory protocols for low-biomass tissue analysis with strict contamination controls. They also propose exploring oral pathogens or their signatures in saliva and blood as biomarkers for risk stratification, prognosis, or immunotherapy response prediction.

Clinical translation remains speculative but not far-fetched. Although no clinical trials of antimicrobial therapy in breast cancer yet exist, preliminary evidence from colorectal cancer, where F. nucleatum is a well-established modulator of tumor behavior and chemoresistance, suggests that modulating this bacterium could improve treatment responses. Future randomized trials might evaluate bacteriophage therapy, probiotics, or targeted antibiotics to test whether reshaping the oral and intratumoral microbiota alters the course of breast cancer. For now, the message for patients is measured: there is no evidence that a root canal infection causes breast cancer, and no reason for alarm. But the mouth, it turns out, may still have something to say about how the disease behaves, and researchers are listening closely.

Subject of Research: Association between root canal-associated oral bacteria and breast cancer incidence and progression

Article Title: Association of root canal bacteria with breast cancer: a systematic review and meta-analysis

Article References: Kaur, J., Gautam, G., Ashinze, P. T., Singh, J., & Nwafor, K. (2026). Association of root canal bacteria with breast cancer: a systematic review and meta-analysis. Holistic Integrative Oncology, 5(1), Article 31. https://doi.org/10.1007/s44178-026-00254-z

Image Credits: AI Generated

DOI: 10.1007/s44178-026-00254-z

Keywords: breast cancer, root canal bacteria, Fusobacterium nucleatum, Porphyromonas gingivalis, Enterococcus faecalis, oral microbiome, meta-analysis, systematic review, tumor microbiome, immune evasion, periodontal disease, cancer progression